Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Thursday, May 23, 2024 1 min read
Key Takeaway: Nautilus Biotechnology, Inc. will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, scheduled for June 10, 2024. The company's management will take part in a fireside chat at 8:40 a.m. Eastern Time. This event allows Nautilus to present its innovative protein analysis platform to a wider audience and demonstrates its commitment to the field of proteomics. Interested parties can access the presentation via Nautilus' website.
Market Sentiment Analysis
POSITIVE FACTORS
Participation in a prestigious conference indicates credibility.
Opportunity to gain visibility among potential investors.
Showcases advancements in their single-molecule protein analysis platform.
Full Press Release Details
SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the Goldman Sachs 45th Annual Healthcare Conference.
Nautilus’ management is scheduled to participate in a fireside chat on Monday, June 10, 2024, at 8:40 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.